Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $655 at Cowen

August 3, 2022 1:42 PM
Cowen analyst Tyler Van Buren raised the price target on Regeneron Pharma (NASDAQ: REGN) to $655.00 (from $645.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles